TYK Medicines (02410) Announces Monthly Securities Movements for January 2026
Bulletin Express
Feb 03
TYK Medicines (02410) submitted its Monthly Return for the period ended January 31, 2026, reporting no changes in the registered share capital. The total authorized/registered share capital remained at RMB380,065,818, comprising 375,457,818 H shares and 4,608,000 unlisted shares.
The company confirmed that 375,457,818 H shares and 4,608,000 unlisted shares were issued as of January 31, with no treasury shares. No changes were recorded in share options, warrants, or any convertible securities during the period. The company further confirmed compliance with the 25% public float requirement for its H shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.